JP2016117676A5 - - Google Patents

Download PDF

Info

Publication number
JP2016117676A5
JP2016117676A5 JP2014257747A JP2014257747A JP2016117676A5 JP 2016117676 A5 JP2016117676 A5 JP 2016117676A5 JP 2014257747 A JP2014257747 A JP 2014257747A JP 2014257747 A JP2014257747 A JP 2014257747A JP 2016117676 A5 JP2016117676 A5 JP 2016117676A5
Authority
JP
Japan
Prior art keywords
component
lactoferrin
fucoxanthin
metabolite
ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014257747A
Other languages
English (en)
Japanese (ja)
Other versions
JP6399920B2 (ja
JP2016117676A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2014257747A external-priority patent/JP6399920B2/ja
Priority to JP2014257747A priority Critical patent/JP6399920B2/ja
Priority to KR1020177015167A priority patent/KR20170095843A/ko
Priority to PCT/JP2015/085450 priority patent/WO2016098874A1/ja
Priority to CN201580069149.8A priority patent/CN107106633A/zh
Priority to TW104142587A priority patent/TWI691334B/zh
Publication of JP2016117676A publication Critical patent/JP2016117676A/ja
Publication of JP2016117676A5 publication Critical patent/JP2016117676A5/ja
Publication of JP6399920B2 publication Critical patent/JP6399920B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014257747A 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤 Active JP6399920B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2014257747A JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤
TW104142587A TWI691334B (zh) 2014-12-19 2015-12-18 內服用組成物、製劑、與用途
PCT/JP2015/085450 WO2016098874A1 (ja) 2014-12-19 2015-12-18 内服用組成物
CN201580069149.8A CN107106633A (zh) 2014-12-19 2015-12-18 内服用组合物
KR1020177015167A KR20170095843A (ko) 2014-12-19 2015-12-18 내복용 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014257747A JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤

Publications (3)

Publication Number Publication Date
JP2016117676A JP2016117676A (ja) 2016-06-30
JP2016117676A5 true JP2016117676A5 (https=) 2017-08-17
JP6399920B2 JP6399920B2 (ja) 2018-10-03

Family

ID=56126754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014257747A Active JP6399920B2 (ja) 2014-12-19 2014-12-19 体脂肪低減剤、体重減少促進剤、血中中性脂肪低減剤及び血中遊離脂肪酸低減剤

Country Status (5)

Country Link
JP (1) JP6399920B2 (https=)
KR (1) KR20170095843A (https=)
CN (1) CN107106633A (https=)
TW (1) TWI691334B (https=)
WO (1) WO2016098874A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006083102A (ja) * 2004-09-16 2006-03-30 Four Leaf Japan:Kk 抗酸化組成物およびこれを含む製品
EP1884238B1 (en) * 2005-05-24 2013-06-26 Kaneka Corporation Fucoxanthinol as anti-obesity agent
JP5158307B2 (ja) * 2006-09-15 2013-03-06 ライオン株式会社 脂肪減少促進剤及び代謝異常症候群改善薬
CN101721403A (zh) * 2008-10-16 2010-06-09 北京绿色金可生物技术股份有限公司 岩藻黄素在减肥方面的应用
JP2011001333A (ja) * 2009-06-22 2011-01-06 Lion Corp アシル−ＣｏＡ合成阻害剤
CN103327999B (zh) * 2011-01-21 2016-08-10 狮王株式会社 促进脂肪分解组合物
JP2013060402A (ja) * 2011-09-14 2013-04-04 Furabamin:Kk フコキサンチンおよびフコイダン含有組成物
US20150216779A1 (en) * 2012-08-14 2015-08-06 The Texas A&M University System Compositions for targeted anti-aging therapy
CN103012327B (zh) * 2012-12-21 2015-05-13 国家海洋局第三海洋研究所 岩藻黄质的制备方法
JP6208604B2 (ja) * 2014-03-14 2017-10-04 ライオン株式会社 体脂肪低減剤

Similar Documents

Publication Publication Date Title
CR20170242A (es) Benzamidas sustituidas copn 1,3-tiazol-2-ilo
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
EP4650370A3 (en) Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
WO2017037594A3 (zh) 用于减少局部脂肪的医药组成物及其用途
HK1244429A1 (zh) 特别用於治疗注意力缺陷障碍的方法和组合物
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
WO2014147182A3 (en) Substituted n-biphenyl-3-acetylamino-benzamides and n-[3-(acetylamino)phenyl]-biphenyl-carboxamides and their use as inhibitors of the wnt signalling pathway
FI3041579T3 (fi) Suun kautta annettavia loislääkekoostumuksia
NI201900063A (es) Amidas aromáticas de ácido carboxílico
JP2015504860A5 (https=)
UY36273A (es) Composicion para el tratamiento de neuropatías y del dolor neuropático
JP2016175884A5 (https=)
WO2018093237A3 (ko) 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
JP2016117676A5 (https=)
EA201500694A1 (ru) Монолитная лекарственная форма для модифицированного высвобождения комбинации активных ингредиентов
JP2017001966A5 (https=)
AR102132A1 (es) Composición cosmética y/o farmacéutica en forma de dispersión, procedimiento de preparación y utilización para el tratamiento de la piel
WO2016175546A3 (ko) 리바스티그민 함유 서방출 의약조성물
JP2014101346A5 (https=)
UY36598A (es) Composición para el tratamiento de neuropatías y/o dolor neuropático
WO2017025896A3 (en) Compositions and methods for treating wounds
JP2017530142A5 (https=)
UA116517C2 (uk) Фармацевтична композиція для лікування захворювань шлунково-кишкового тракту
JP2015113322A5 (https=)